Stock market today, January 29, 2015: U.S. stock futures for Thursday, Jan. 29, forecasted a 33-point gain from yesterday’s close. The Dow Jones shed 195 points on Wednesday following a U.S. Federal Reserve statement about interest rates issued at the conclusion of the FOMC meeting.Today, investors will focus on a busy day of earnings reports that includes quarterly updates from Google Inc. (Nasdaq: GOOG, […]
Market dilemma: Accurate government data
Discussing today’s weak retail sales data and Obamacare’s impact on the overall economy, with Kim Caughey Forrest, Fort Pitt Capital Group; Keith Fitz-Gerald, Money Map Press; Kenny Polcari, O’Neil Securities; and CNBC’s Steve Liesman.
Investors are getting hit from all sides — the World Bank cut its global growth forecast, oil and other commodities are under more […]
Watch tonight’s video market recap on my Ticker.tv channel, Mark333.Another day of selling an up open hit the market Tuesday. Yesterday we had a premarket push and that was sold off within minutes at the open. Today we had an even larger premarket rally and a big push up to begin the day, but sellers came in again mid day […]
Markets ended in the red zone for the second-consecutive day on Monday as oil price slide continued to dent investor sentiment. Moreover, dismal earnings outlook also dragged down benchmarks yesterday. However, some merger and acquisition news limited day’s losses. More than 75% of the Dow components ended in negative territory on Monday.For a look at the issues currently facing the […]
BLAIN UPDATE – Interview with Ross Cameron of DayTradeWarrior now available for viewing!Watch tonight’s video market recap on my Ticker.tv channel, Mark333.Indexes continue to be troubled with the drop in oil as the S&P 500 fell 0.81% and the NASDAQ 0.84%. As we said Friday, in good markets you don’t sell good news and that is what happened on the […]
Myles Udland
Jan. 6, 2015, 3:15 PM
6,714
Wikimedia CommonsSee Also5 Ways A Low Oil Price Affects The Global Political LandscapeBILL GROSS: ‘The Good Times Are Over’It’s Like We’re In The Panic Phase Of A Financial CrisisTuesday was another ugly day on Wall Street.And we almost had another “since 2008” stat that stock bulls weren’t going to like.Earlier on Tuesday, the S&P 500 was […]
Guest post written byPaul KarosPaul Karos is a senior portfolio manager at Minneapolis-based Whitebox Advisors, which manages over $4 billion in hedge and mutual funds.Health care stocks have enjoyed a persistent bid in the markets over the past three years. Health care was second best performing sector in the S&P 500 during the choppy markets of 2014 (up 23%, […]
Sovaldi pill. Source: Gilead SciencesGilead Sciences had another phenomenal year in 2014, returning 26% for investors. That’s more than double the return of the broad-based S&P 500 , and it has hepatitis C drug Sovaldi to thank.In just the first nine months of 2014, Sovaldi netted Gilead $8.55 billion in sales. It’s the most effective drug launch in history by […]
We had some technical difficulties tonight so no market recap video today but I posted an idea session last night where we looked at some recent winners to see which names might be good ideas go forward, on my Ticker.tv channel, Mark333.Indexes opened down as oil weighed, and stayed weak all day in a quite miserable session. Investors have become […]
Source: GlaxoSmithKline via Flickr.When it comes to healthcare events, there is none more important than the JPMorgan Healthcare Conference. Filled with dozens upon dozens of biotech and medical device companies, the JPMorgan Healthcare Conference, coming up in mid-January, is the perfect time for companies to unveil a study or device they’ve been keeping under their thumb for a rainy day.With […]
